Edward E. Koval
Corporate Officer/Principal bei GERON CORPORATION
Aktive Positionen von Edward E. Koval
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01.12.2021 | - |
Karriereverlauf von Edward E. Koval
Ehemalige bekannte Positionen von Edward E. Koval
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.01.2013 | 01.01.2020 |
Zebiai Therapeutics, Inc.
 Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Corporate Officer/Principal | - | - |
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 04.04.2012 | - |
Ausbildung von Edward E. Koval
| New York University | Undergraduate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Dänemark | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Technology Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |
- Börse
- Insiders
- Edward E. Koval
- Erfahrung